Brian M Shuch (Brian Shuch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Renal Cell Carcinoma

Radical Prostatectomy

Top Venues

BJU international

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A Murray, Samantha Liu, Dipti P Sajed, Chana Sachs, Joshua Spurrier, Mitch Raponi, Jiayu Liang, Hao Zeng, Ranjini K Sundaram, Brian M Shuch, Juan C Vasquez, Ranjit S Bindra
NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion. Molecular cancer research : MCR (2024)
Abhishek Tripathi, Catherine M Tangen, Melissa Plets, Xiaochen Li, Maria Tretiakova, Peter A Humphrey, Adebowale Adeniran, Pedro C Barata, Shuchi Gulati, Cristiane Decat Bergerot, Deepak K Pruthi, Ian M Thompson, Primo N Lara, Seth P Lerner, Sumanta K Pal, Brian M Shuch
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. BJU international (2024)
Pedro C Barata, Catherine M Tangen, Melissa Plets, Ian M Thompson, Vivek Narayan, Daniel J George, Daniel Y C Heng, Brian M Shuch, Mark N Stein, Shuchi Gulati, Maria Tretiakova, Abhishek Tripathi, Georg Arnold Bjarnason, Peter Humphrey, Adebowale Adeniran, Ulka N Vaishampayan, Ajjai Alva, Tian Zhang, Scott Cole, Primo N Lara, Seth P Lerner, Naomi B Haas, Sumanta Kumar Pal
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G Nair, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Gruenwald
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Blake R Wilde, Nishma Chakraborty, Nedas Matulionis, Stephanie Hernandez, Daiki Ueno, Michayla E Gee, Edward D Esplin, Karen Ouyang, Keith Nykamp, Brian M Shuch, Heather R Christofk
FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer. Cancer discovery (2023)
Robert E Reiter, Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A Proudfout, Yang Liu, Lisa Webber, Arkaitz Ibarra, Vinnie Y T Liu, Elai Davicioni, Karim Chamie, Allan Pantuck, Brian M Shuch
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer. Cancer medicine (2022)
Gennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, James Brugarolas, Mark W. Ball, Adam Metwalli, Katherine L Nathanson, Phillip M Pierorazio, Ronald S Boris, Eric A Singer, Maria I Carlo, Mary B Daly, Elizabeth P Henske, Colette Hyatt, Lindsay Middleton, Gloria Morris, Anhyo Jeong, Vivek Narayan, W Kimryn Rathmell, Ulka N Vaishampayan, Bruce H Lee, Dena Battle, Michael J Hall, Khaled Hafez, Michael A S Jewett, Christina Karamboulas, Sumanta Kumar Pal, A Ari Hakimi, Alexander Kutikov, Othon Iliopoulos, W Marston Linehan, Eric Jonasch, Ramaprasad Srinivasan, Brian M Shuch
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement. Cancer 127 (21) (2021)
Eric Lu, Kathryn E Hatchell, Sarah M Nielsen, Edward D Esplin, Karen Ouyang, Keith Nykamp, Shirin Zavoshi, Shantao Li, Zarina Yelskaya, Blake R Wilde, Heather R Christofk, Paul C Boutros, Brian M Shuch
Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer (2021)
Brian M Shuch, Shantao Li, Harvey Risch, Ranjit S Bindra, Patrick D McGillivray, Mark Gerstein
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer 126 (16) (2020)
Jun Tu Zhen, Jamil Syed, Kevin Anh Nguyen, Michael S Leapman, Neeraj Agarwal, Karina Brierley, Xavier Llor, Erin Hofstatter, Brian M Shuch
Genetic testing for hereditary prostate cancer: Current status and limitations. Cancer 124 (15) (2018)
Jamil S Syed, Kevin A Nguyen, Theodore R Holford, Jonathan N Hofmann, Brian M Shuch
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis. Cancer 125 (2) (2018)
Jamil S Syed, Kevin A Nguyen, Alfredo Suarez-Sarmiento, Katelyn Johnson, Michael S Leapman, Jay D Raman, Brian M Shuch
Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment. BJU international 121 (1) (2017)
Kevin A Nguyen, Jamil S Syed, Carin R Espenschied, Holly LaDuca, Ansh M Bhagat, Alfredo Suarez-Sarmiento, Timothy K O'Rourke, Karina L Brierley, Erin W Hofstatter, Brian M Shuch
Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test. Cancer 123 (22) (2017)